MCA Overseas Listing Rules 2026: G.S.R. 968(E) Explained
The short answer
On 3 November 2026, India’s Ministry of Corporate Affairs notified G.S.R. 968(E) — the Companies (Listing of equity instruments in permissible jurisdictions) Amendment Rules, 2026. The rules took effect the same day they were published in the Official Gazette. In plain English: Indian public companies get a wider route to list abroad. The amendment (1) expands “equity shares” to equity instruments (equity shares, convertible debentures and preference shares), (2) expressly covers unlisted public companies in IFSC / GIFT City under the IFSCA Act, 2019, and (3) lets negative-net-worth companies list overseas if they undertake to allot at least 75% of the net offer to qualified institutional buyers (QIBs) under the overseas regulator’s rules. Form LEAP-1 was also replaced.
Why this notification matters
For years, India’s policy pitch has been: build companies here, but do not force every growth story into a domestic IPO template that does not fit. Direct overseas listing in “permissible jurisdictions” was opened in 2024 through the Companies (Listing of equity shares in permissible jurisdictions) Rules, 2024, under Section 23(3) of the Companies Act, 2013. That first rulebook was deliberately narrow — mostly equity shares, with tight eligibility bars.
G.S.R. 968(E) is the first major rewrite. It does not create a free-for-all. It widens the product set, aligns IFSC entities, and creates a controlled escape hatch for issuers that previously failed the net-worth test. Founders, CFOs, merchant bankers and overseas exchange counsel should read it as a capital-markets design change, not a press-release slogan.
What changed, clause by clause
1. “Shares” become “instruments”
Throughout the 2024 principal rules, “shares” is substituted with “instruments.” A new definition is inserted: “equity instruments” means equity shares, convertible debentures, preference shares issued by an Indian Company. From 3 November 2026, three product types — not one — sit inside the overseas-listing perimeter.
That matters for capital structure design. A company that needs hybrid capital (convertibles) or a preference stack for overseas institutional buyers can now structure the offshore offer inside the MCA framework rather than inventing workarounds that regulators dislike.
2. IFSC / GIFT City companies get an express lane
Rule 3 of the principal rules is amended in two strokes. Public companies in International Financial Services Centres are carved out of the general clause, and a new clause covers unlisted public companies in IFSC jurisdiction so far as they comply with the International Financial Services Centres Authority Act, 2019 and regulations under it.
GIFT City has been building listing, finance-company and fund infrastructure. The MCA amendment stops treating IFSC issuers as an awkward fit inside the mainland clause and instead points them at the IFSCA rulebook. For a GIFT City holding or operating company considering an international exchange listing, that clarity is the difference between a clean counsel opinion and a six-month interpretive fight.
3. Negative net worth + 75% QIB path
Rule 5(d) previously blocked companies with negative net worth. The amendment inserts a proviso: such a company may issue equity instruments for listing if it undertakes to allot at least seventy-five per cent of the net offer to QIBs, in line with the securities regulator of the permissible jurisdiction where the listing happens.
Read that carefully. The 75% test is measured against the overseas regulator’s QIB (or equivalent) definition — not SEBI’s domestic QIB list copied wholesale. The discipline is intentional: institutional demand must anchor the book when the balance sheet is underwater on a net-worth test.
4. Softening two other eligibility bars
The default-related bar in rule 5(e)’s proviso moves from a two-year lookback flavour to more than six months (as amended).
Rule 5(g)’s payment-default bar now applies only where the default has not been made good.
Together, these changes reduce “gotcha” disqualifications for companies that fixed old defaults but still carried a stale technical bar.
5. Form LEAP-1 replaced
The Second Schedule form is substituted. Coverage of the new LEAP-1 notes fields for overseas regulator/exchange approval, prospectus filing dates, and whether inspection, investigation or inquiry has been ordered — plus attachments and a practising professional’s certificate. Compliance teams should retire old templates immediately.
How the overseas-listing stack fits together
MCA rules sit beside:
Companies Act, 2013 Section 23(3) authority for listing in permissible jurisdictions.
SEBI / RBI / FEMA conditions that still govern capital account, pricing and investor protection when Indian companies raise abroad.
Permissible jurisdiction lists (international exchanges notified for this route).
For IFSC issuers, IFSCA regulations.
G.S.R. 968(E) does not repeal those layers. It widens the MCA gate. A company that clears MCA eligibility can still fail an exchange listing standard, a foreign prospectus regime, or an Indian exchange-control condition. Treat this as necessary but not sufficient.
Who should care first
Deep-tech and biotech founders. Long R&D cycles often mean years of accounting losses. The 75% QIB path is not a retail free-for-all; it is a way for institutional books to underwrite binary technical risk offshore while India keeps the corporate home.
IFSC / GIFT City platforms. Unlisted public companies there now have an express overseas-listing mention tied to IFSCA compliance — useful for finance, leasing and holding structures being built in the IFSC.
CFOs of mid-cap public companies. Convertible and preference instruments can now be part of an overseas offer design under the amended rules, subject to other laws.
Legal and audit teams. LEAP-1, “existing holders” language (replacing “existing shareholders”), and remedied-default wording change diligence checklists overnight.
What did *not* change
India did not abolish domestic IPO rules.
Retail investor protection abroad remains the job of the host exchange and its regulator.
Permissible jurisdictions are still a defined set — this is not “list anywhere.”
SEBI’s Innovators Growth Platform review (announced days earlier) is a separate domestic track for innovation-led listings. Do not conflate IGP reforms with MCA overseas-listing amendments.
A worked example: negative net worth issuer
Imagine an unlisted Indian public company with accumulated losses and negative net worth, but a clear institutional story (say, a deep-tech hardware firm with signed offtake LOIs). Under the 2024 rules, the negative-net-worth bar was a hard stop for this overseas route. Under G.S.R. 968(E), the company can proceed if it undertakes that ≥75% of the net offer goes to QIBs under the host market’s rules, and if every other eligibility, FEMA and exchange condition is met.
That does not mean the deal is easy. Host exchanges still demand disclosure, sponsors/underwriters still demand comfort, and Indian regulators still watch round-tripping and valuation games. It means the MCA door is no longer locked solely because net worth is negative on the balance sheet.
Instruments: why convertibles and prefs matter
Equity shares are blunt. Convertible debentures let issuers bridge valuation gaps and give overseas funds downside structure. Preference shares can encode liquidation waterfalls familiar to global PE. By defining all three as “equity instruments,” MCA acknowledges how real growth capital is priced — especially for companies that are not yet ready for a plain-vanilla common-share IPO narrative.
Counsel will still need to reconcile instrument terms with Indian company-law limits, stamp, tax and FEMA classification. The amendment removes the MCA-product mismatch; it does not auto-approve every hybrid.
IFSC angle in one paragraph
GIFT City’s pitch is: Indian time zone, international rule sets, rupee and foreign-currency products, and a bridge between domestic promoters and global pools. Expressly covering IFSC unlisted public companies inside the overseas-listing rules reduces the chance that a GIFT City issuer falls between IFSCA and MCA stools. Expect more dual-track conversations: list on an IFSC exchange stack, or use IFSC incorporation as a staging ground toward a permissible overseas exchange — always subject to the actual IFSCA and host-market rulebooks, not LinkedIn threads.
Timeline of the overseas-listing policy
Practical checklist for boards (next 30 days)
Confirm whether the company is mainland or IFSC for rule 3 purposes.
Recompute net worth under the definition used in the principal rules; if negative, model a ≥75% QIB allotment undertaking.
Decide the instrument (equity / convertible / preference) against investor demand and FEMA classification.
Map the target permissible jurisdiction and its QIB-equivalent definition.
Update board papers and secretarial templates for new LEAP-1.
Parallel-track SEBI/RBI/FEMA and tax opinions — MCA clearance alone is not a closing condition set.
Stress-test disclosure: negative net worth + overseas retail optics can create headline risk even when the book is institutional.
How this interacts with India’s domestic innovation-listing debate
Days before G.S.R. 968(E), SEBI constituted a working group on the Innovators Growth Platform. Domestic IGP reform and overseas-listing widening are complements, not substitutes. Some companies will want a domestic innovation board with Indian retail/institutional mix. Others will want hard-currency listing, global peer multiples, and QIB-heavy books abroad. Policy now nudges both doors more open. The competitive question for India is whether high-quality issuers still feel forced to flip into foreign holdcos — a pattern New Delhi has tried to reverse for half a decade.
Risks and open questions
Will exchanges and investors actually clear negative-net-worth names? The MCA gate opened; market taste is untested.
How will “QIB” map across jurisdictions? Undertakings must track the host regulator’s definition precisely.
Tax and FEMA friction can still kill a beautifully drafted MCA-compliant offer.
Retail optics: even with 75% QIB, residual allotment and secondary trading can put Indian brand risk on foreign screens.
Form LEAP-1 enforcement: expect sharper professional certificates and inquiry disclosures.
None of these are reasons to ignore the notification. They are reasons to staff the deal with people who have shipped cross-border offerings before.
Bottom line
G.S.R. 968(E) is a real widening of India’s direct overseas-listing framework: more instruments, clearer IFSC coverage, a QIB-anchored path for negative net worth, softer default bars, and a new LEAP-1. Effective 3 November 2026. If you are raising growth capital with a cross-border listing thesis, update the board memo this month — and still run the full securities, FEMA and tax stack.
Comparing the 2024 rules to the 2026 amendment
The 2024 framework answered a political and economic question: should high-quality Indian companies be forced into foreign holding companies simply to access global exchanges? Direct listing was the answer — but the first draft was cautious. Equity shares only. Strict eligibility. Limited explicit treatment of IFSC entities. Negative net worth as a near-absolute bar.
The 2026 amendment keeps the caution on investor quality (especially the 75% QIB anchor) while admitting that real companies raise with hybrids, that GIFT City is now a serious incorporation venue, and that accounting net worth is a blunt instrument for R&D-heavy issuers. In other words: same policy goal, less brittle plumbing.
For bankers, the practical difference shows up in the first client memo. In 2024 you asked: “Can we list common shares on a permissible exchange?” In 2026 you also ask: “Should the primary be convertibles? Is the issuer an IFSC public company? If net worth is negative, can we build a QIB-heavy book that still clears host-market rules?” Those are better questions. They produce better deals — or faster “no” decisions before fees burn.
What “permissible jurisdiction” still means
Nothing in G.S.R. 968(E) turns every global exchange into an eligible venue. The overseas-listing route still depends on jurisdictions and exchanges recognised for this purpose under the broader policy stack. Boards should not confuse “MCA widened instruments” with “any ticker, any country.” Exchange selection remains a gated legal and commercial choice: liquidity, peer set, index inclusion odds, disclosure culture, and geopolitical comfort for Indian promoters all matter.
Host-market prospectus liability also differs. US-style regimes, UK/European regimes and IFSC-linked venues do not price risk the same way. The MCA amendment changes what Indian company law permits you to offer; it does not rewrite overseas civil liability.
Governance and disclosure expectations after LEAP-1
The replaced Form LEAP-1 emphasises regulator/exchange approvals, prospectus dates, and whether inspection or investigation has been ordered. That is a signal. MCA wants a cleaner paper trail when Indian companies step onto foreign boards. Practising professionals who certify LEAP-1 attachments should assume their certificates will be read in both Delhi and the host market.
For audit committees, the right response is boring and correct: update the secretarial checklist, refresh related-party and investigation registers, and ensure the board minutes record the overseas-listing rationale, instrument choice, and QIB undertaking (if used) before marketing starts.
Scenarios where overseas listing still loses to a domestic IPO
The investor base you want is overwhelmingly Indian mutual funds and retail.
You need index inclusion in Nifty/Sensex ecosystems more than hard-currency listing prestige.
Your story is already main-board ready on profits and disclosure.
FEMA, tax or promoter lock-in friction makes a dual structure uneconomic.
Overseas listing is a tool. G.S.R. 968(E) makes the tool sharper. It does not make it the default.
How CFOs should brief the board in one slide
Headline: MCA G.S.R. 968(E) effective 3 Nov 2026 widens direct overseas listing.
Three bullets: instruments expanded; IFSC unlisted publics covered; negative NW allowed with ≥75% QIB.
Ask: approve exploration of [jurisdiction/exchange], instrument preference, and parallel FEMA/tax workstreams; no marketing until LEAP-1 pack and counsel memos are green.
Risk line: host-market clearance and Indian exchange-control remain gating — MCA is not the finish line.
Keep that slide factual. Markets punish overclaiming on regulatory “green lights.”
Frequently asked questions
When did G.S.R. 968(E) take effect?
3 November 2026, the date of publication in the Official Gazette.
What instruments can be listed overseas under the amended rules?
Equity shares, convertible debentures and preference shares issued by an Indian company — collectively “equity instruments.”
Can a company with negative net worth list overseas now?
Yes, if it undertakes to allot at least 75% of the net offer to QIBs under the host market regulator’s rules, and meets other eligibility conditions.
Are IFSC companies covered?
Unlisted public companies in IFSC jurisdiction are expressly covered to the extent they comply with the IFSCA Act, 2019 and its regulations.
Did this change SEBI’s Innovators Growth Platform?
No. IGP is a separate domestic listing framework; SEBI’s Nov 2026 working group is a parallel track.
Related reading on Page Twenty One
Sources
MCA Notification G.S.R. 968(E) dated 3 November 2026 (Companies (Listing of equity instruments in permissible jurisdictions) Amendment Rules, 2026), as summarised in TaxGuru, CorpLawUpdates, CA Club India and TaxByKK explainers citing the Gazette text; Companies Act, 2013 s.23(3); IFSCA Act, 2019 references in the amendment. Last updated 7 November 2026 (Asia/Calcutta).
Comments